Results 31 to 40 of about 319,380 (216)

Delayed Diagnosis of Psoriatic Arthritis Mutilans due to Arthritis Prior to Skin Lesion

Case Reports in Rheumatology, 2018
Psoriatic arthritis (PsA) is a type of inflammatory arthritis characterized by cutaneous psoriasis, peripheral joint damage, axial joint damage, and enthesitis and is usually diagnosed after the appearance of psoriatic skin disease.
Takeshi Mochizuki, Katsunori Ikari, Ken Okazaki   +2 more
doaj   +1 more source

The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis register [PDF]

BMC Rheumatology, 2021
Abstract Background Psoriatic arthritis (PsA) presents a unique clinical challenge. Affecting joints, skin, nails, and other organs, it is associated with various comorbidities and has a significant impact on quality of life, social participation and working life.
Jones, Gareth T., Macfarlane, Gary J., Forrest Keenan, Karen, McNamee, Paul, Neilson, Aileen R., Siebert, Stefan, Burden, A. David, Kay, Lesley, Helliwell, Philip S.   +8 more
openaire   +6 more sources

AB0780 TREATMENT PERSISTENCE OF BIOLOGICS AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PsA) [PDF]

Annals of the Rheumatic Diseases, 2020
Background: Persistence in biologic therapy in psoriatic arthritis is critical to optimize symptom remission, functional capacity and health care costs. Objectives: To estimate the persistence to biologic treatment prescribed to PsA patients in a real-life setting as well as factors associated with improved biologic drug survival in these patients.
A. Haddad, T. Gazitt, I. Feldhamer, J. Feld, A. Cohen, D. Zisman   +5 more
openaire   +1 more source

SAT0347 Baseline characteristics of patients with psoriatic arthritis initiated on apremilast in the corrona psoriatic arthritis/spondyloarthritis (PSA/SPA) registry [PDF]

Annals of the Rheumatic Diseases, 2018
Background Apremilast (APR) is an oral phosphodiesterase 4 inhibitor approved for the treatment of adult patients with active psoriatic arthritis (PsA) and psoriasis. Objectives To characterise demographics, disease activity and duration, concomitant therapy, quality of life, and prior comorbidities among patients with PsA who initiated APR in the ...
P.J. Mease, E. Rosenstein, H. Feng, M. Liu, B. Guerette, L. Teng, S. Rebello, A.R. Ogdie-Beatty   +7 more
openaire   +3 more sources

Classification and Outcome Measures for Psoriatic Arthritis

Frontiers in Medicine, 2018
Psoriatic arthritis (PsA) is an inflammatory arthritis with multiple manifestations: peripheral/axial arthritis, enthesitis, dactylitis, psoriasis, and nail involvement.
Ying Ying Leung, Alexis Ogdie, Ana-Maria Orbai, William Tillett, Laura C. Coates, Vibeke Strand, Philip Mease, Dafna D. Gladman   +7 more
doaj   +1 more source

The current status and unmet needs in the management of psoriatic arthritis: Viewpoint from physicians in Taiwan

Journal of the Formosan Medical Association, 2018
Background/Purpose: To analyze the real-world clinical practice for the treatment of psoriatic arthritis (PsA) and to assess physicians' prescription, difficulties in diagnosis, therapeutic strategy, rationales for biologic therapies and unmet needs in ...
Tzu-Hao Li, Hsien-Tzung Liao, Yi-Fan Huang, Yu-Chuan Shen, Yao-Chang Chiu, Wei-Sheng Chen, Ming-Han Chen, Chang-Youh Tsai, Deh-Ming Chang   +8 more
doaj   +1 more source

Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization [PDF]

, 2012
Introduction: In recent genome-wide association studies for psoriatic arthritis (PsA) and psoriasis vulgaris, common coding variants in the TRAF3IP2 gene were identified to contribute to susceptibility to both disease entities.
Maria Apel, Böhm, Beate B., Steffen Uebe, Böhm, Beate, Apel, Maria, Behrens, Frank, Harald Burkhardt, Frank Behrens, Burkhardt, Harald, Beate Bohm, Hüffmeier, Ulrike, Ulrike Huffmeier, Reis, André, Uebe, Steffen, Andre Reis   +14 more
core   +1 more source

A Study of Intima Media Thickness and Their Cardiovascular Risk Factors in Patients with Psoriatic Arthritis

Acta Medica, 2009
Introduction: Psoriatic Arthritis (PsA) is an inflammatory arthritis associated with Psoriasis. Its recognition as an inflammatory disease distinct from Rheumatoid Arthritis has put forward for consideration several questions regarding its specific CVS ...
Sadhanah Aqashiah Mazlan, Mohd Shahrir bin Mohamed Said, Heselynn Hussein, Khadijah binti Shamsuddin, Shamsul Azhar Shah, Hamidon Basri   +5 more
doaj   +1 more source

ASSESSMENT OF SUBCLINICAL INNER EAR DYSFUNCTION IN PSORIATIC ARTHRITIS PATIENTS [PDF]

Zagazig University Medical Journal, 2019
Introduction: In patients with spondyloarthropathies, underlying autoimmune mechanisms and vasculitis may affect audiovestibular system. In previously presented studies, presence of sensory neural hearing loss (SNHL) was detected in some patients with ...
Marwa Hammad, Soha Abd-el Raouf Mekki, Omaima Zakaria Shehata, Hager Nabil Bayoumi Ahmed   +3 more
doaj   +1 more source

Psoriatic arthritis treatment to the target: a consensus, evidence-based clinical practice recommendations for the management of psoriatic arthritis and its concomitant clinical manifestations

, 2022
Background We aimed to provide up-to-date, evidence-based and consensus-based recommendations for Treat-to-Target management of psoriatic arthritis (PsA) and associated clinical manifestations.
GadAllah, N, Medhat, B, Galal, S, Adel, Y, Fathy, N, Eissa, M, Saber, S, Elkaraly, N, Mansour, M, El Olemy, G, El Gaafary, M., Ghaleb, R, Foad, N, Ali, R, El-Latif, E A, Mortada, M, El Miedany, Y., Allen, A., Abu-Zaid, M., Hassan, W, Tabra, S A   +20 more
core   +1 more source